+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Controlled clinical trial of imidazole.2-hydroxybenzoate (ITF 182) versus sulindac in patients with rheumatoid arthritis

Controlled clinical trial of imidazole.2-hydroxybenzoate (ITF 182) versus sulindac in patients with rheumatoid arthritis

Clinical Therapeutics 8(3): 292-300

The efficacy and safety of the nonsteroidal anti-inflammatory drugs imidazole.2-hydroxybenzoate and sulindac were compared in 30 patients with classical or definite rheumatoid arthritis. The trial was designed as a randomized parallel-group study comprising 15 patients given imidazole.2-hydroxybenzoate and 15 given sulindac orally for 28 days. Patients in both groups improved significantly in almost all of the variables evaluated. Imidazole.2-hydroxybenzoate was more effective than sulindac on Ritchie's articular index, left hand proximal interphalangeal joint circumference, erythrocyte sedimentation rate, and C-reactive protein. The incidence of side effects was significantly higher in patients treated with sulindac.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 039683556

Download citation: RISBibTeXText

PMID: 3521858

Related references

Multicenter double-blind randomized clinical trial of imidazole salicylate versus ibuprofen in patients with rheumatoid arthritis. International Journal of Clinical Pharmacology Therapy and Toxicology 25(8): 443-447, 1987

OP0041Tocilizumab (TCZ) in Combination and Monotherapy Versus Methotrexate (MTX) in MTX-Naive Patients (PTS) with Early Rheumatoid Arthritis (RA): Clinical and Radiographic Outcomes from a Randomised, Placebo-Controlled Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A63.1-A63, 2013

An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis. Drug Design Development and Therapy 11: 985-994, 2017

Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis and Rheumatism 42(9): 1870-1878, 1999

Treatment of rheumatoid arthritis with imidazole-2-hydroxybenzoate or naproxen: study of the efficacy and tolerability. Bollettino Chimico Farmaceutico 124(8): 91s-94s, 1985

Comparison of the Clinical Efficacy and Safety of Subcutaneous Versus Oral Administration of Methotrexate in Patients With Active Rheumatoid Arthritis: Results of a Six-Month, Multicenter, Randomized, Double-Blind, Controlled, Phase IV Trial. Yearbook of Medicine 2009: 17-18, 2009

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial. Arthritis and Rheumatism 58(1): 73-81, 2008

Prospidine versus methotrexate pulse in highly active rheumatoid arthritis: A controlled 6-month clinical trial. Clinical Rheumatology 13(1): 54-59, 1994

Controlled clinical study of the clinical efficacy and tolerability of a new nonsteroidal anti-inflammatory preparation, imidazole-2-hydroxybenzoate, in patients with pain and phlogistic syndromes of varying etiopathogenesis. Bollettino Chimico Farmaceutico 122(12): 37s-49s, 1983

Evaluation of topical human platelet lysate versus topical clobetasol in management of methotrexate-induced oral ulceration in rheumatoid arthritis patients: Randomized-controlled clinical trial. International Immunopharmacology 73: 389-394, 2019

Comparison of daily versus alternate day azathioprine aza in the treatment of rheumatoid arthritis ra a twelve week controlled clinical trial. British Journal of Rheumatology 28(Suppl. 2): 4, 1989

Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial. Annals of the Rheumatic Diseases 75(6): 983-990, 2016

A double blind multicenter study of sulindac once daily versus sulindac twice daily in rheumatoid arthritis. Current Therapeutic Research 41(5): 679-691, 1987

Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial. Current Medical Research and Opinion 23(9): 2259-2268, 2007

A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. Journal of Rheumatology 24(10): 1910-1915, 1997